What is watchful waiting and is it appropriate for my Pancreatic Cancer

Understanding Watchful Waiting in Pancreatic Cancer

I appreciate this important question. Let me explain what watchful waiting is and then address whether it's typically appropriate for pancreatic cancer specifically.

What is Watchful Waiting?

Watchful waiting (also called "active surveillance") means monitoring your condition closely with regular tests and imaging—without starting treatment immediately. Your medical team watches for signs that the cancer is growing or changing, and treatment begins only if specific changes occur.

This approach involves:

• Regular blood tests and imaging (CT scans, MRI, ultrasounds)
• Frequent doctor visits to assess your condition
• Careful documentation of any changes
• Starting treatment when predetermined "trigger points" are reached

The Pancreatic Cancer Context: Why It's Rarely Used

Here's the critical distinction for pancreatic cancer: Watchful waiting is not typically recommended as a standard approach for most pancreatic cancer patients, and here's why:

According to CancerPatientLab's webinar "Navigating Pancreatic Cancer" featuring Dr. [removed] Strickler (Associate Professor of Medical Oncology at Duke University), pancreatic cancer is characterized by:

• Aggressive biology - It grows and spreads quickly
• Poor long-term outcomes with standard care - The disease is difficult to treat once it becomes established
• Limited window of opportunity - Early intervention typically offers better chances than waiting

Dr. [removed] emphasizes: "If we're going to move the needle on pancreatic cancer, we've got to detect this earlier because it is very difficult to cure the disease once it becomes a bulky tumor."

When Watchful Waiting MIGHT Be Considered

There are very specific situations where surveillance may be appropriate:

1. High-Risk Individuals (Not Yet Diagnosed with Cancer)

According to Let's Win Pancreatic Cancer's research on early detection, people with:

• Strong family history of pancreatic cancer
• Genetic mutations (BRCA1, BRCA2, PALB2, Lynch syndrome)
• Hereditary pancreatitis
• New-onset diabetes after age 50

These individuals may undergo intensive surveillance with:

• Annual MRI scans
• Endoscopic ultrasounds
• Blood-based biomarker testing

Research shows that annual surveillance of high-risk patients has significant benefits—when pancreatic cancer is detected in these screened populations, it's often caught at earlier stages, and more than 70% were still alive five years later.

2. Pancreatic Cysts or Precancerous Lesions

Some patients have findings that are not yet cancer but carry risk:

• Intraductal papillary mucinous neoplasms (IPMNs)
• Pancreatic cysts
• Other precancerous changes

In these cases, surveillance may be appropriate while monitoring for progression.

3. Neuroendocrine Tumors (PNETs)

These are a different type of pancreatic cancer than the more common adenocarcinoma. They can sometimes grow more slowly, and surveillance may occasionally be considered depending on grade and stage.

What You Should Ask Your Doctor

If you've been diagnosed with pancreatic cancer, here are critical questions:

1. "What type and stage of pancreatic cancer do I have?" (This determines urgency)
2. "Why is watchful waiting being recommended (or not recommended) for my specific situation?"
3. "What are the risks of delaying treatment in my case?"
4. "What treatment options are available, and what does the timeline look like?"
5. "Have you done molecular profiling and genetic testing on my tumor?" (This may reveal targeted therapy options)
6. "Are there clinical trials I'm eligible for?"

The Bottom Line

According to Let's Win Pancreatic Cancer's guidance on newly diagnosed patients: While pancreatic cancer is serious and requires prompt action, there is always time to get a second opinion unless it's an emergency situation. However, this doesn't mean watchful waiting—it means getting expert evaluation quickly to determine the best treatment approach.

Dr. [removed] Ocean, a gastrointestinal oncologist quoted in the Let's Win resources, emphasizes: "There is always hope and the first thing I would say to a patient diagnosed with this disease is don't accept the sentiment of resignation that pancreatic cancer is impossible to treat. We are making progress and every patient is an individual, not a statistic."

The standard approach for diagnosed pancreatic cancer is typically:

• Rapid evaluation and staging
• Molecular profiling of your tumor
• Discussion of treatment options (surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trials)
• Possible neoadjuvant chemotherapy (treatment before surgery)
• Not watchful waiting

Getting a Second Opinion

If watchful waiting has been suggested for your pancreatic cancer diagnosis, I'd strongly encourage you to seek a second opinion from a pancreatic cancer specialist at a major academic medical center. These centers have access to the latest treatment options and clinical trials that may not be available elsewhere.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.